Universe Pharmaceuticals (UPC) Payables (2020 - 2025)

Universe Pharmaceuticals has disclosed Payables across 6 years of filings, most recently posting $7.4 billion for Q3 2025.

• Payables for Q3 2025 came in at $7.4 billion, up 19.37% year-over-year; the trailing twelve-month figure through Sep 2025 was $7.4 billion (up 19.37% YoY), and the FY2025 annual result was $7.4 billion, up 19.37% from the prior year.
• Payables came in at $7.4 billion for Q3 2025 at Universe Pharmaceuticals, up from $6.2 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $7.4 billion in Q3 2025 to a low of $4.1 million in Q1 2023.
• The 5-year median for Payables is $8.3 million (2021), against an average of $1.7 billion.
• Across the five-year window, Payables slumped 100.0% in 2021 and soared 61577.77% in 2024, its largest moves.
• Universe Pharmaceuticals' Payables stood at $9.6 million in 2021, then retreated by 27.3% to $7.0 million in 2022, then soared by 43.59% to $10.1 million in 2023, then jumped by 61577.77% to $6.2 billion in 2024, then rose by 19.37% to $7.4 billion in 2025.
• The last three Payables figures came in at $7.4 billion (Q3 2025), $6.2 billion (Q3 2024), and $4.4 million (Q1 2024), per Business Quant data.